HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy

Tissue Antigens

Volumn 52, Issue 2, 1998, Pages 130-134

  Vaughan, R W ^a   Zurowska, A ^b   Moszkowska, G ^b   Kondeatis, E ^a   Clark, A G B ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

HBV; HLA class II; Membranous nephropathy; PCR SSP

Indexed keywords

HEPATITIS B VACCINE; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENE FREQUENCY; HEPATITIS B; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NORMAL HUMAN; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

HEPATITIS B VIRUS;

EID: 0031827454     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02276.x     Document Type: Article

References (29)

1. Klouda PT, Manos J, Acheson EJ et al. Strong association between idiopathic membranous nephropathy and HLA-DRw3. Lancet 1979: ii: 770-2.
2. Vaughan RW, Ogahara S, Arquart MJ et al. Idiopathic membranous nephropathy. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Wokshop and Conference. Vol 1. Oxford: Oxford Scientific Pub, 1993: 745-8.
3. Coombs B, Stastny P, Shorey J et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971: ii: 234-7.
4. Takekoshi Y, Tanaka M, Shida N et al. Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 1978: 2(8099): 1065-8.
5. Ito H, Hattori S, Matusda I et al. Hepatitis B e antigen-mediated membranous glomerulonephritis correlation of ultrastructural changes with HBeAg in the serum and glomeruli. Lab Invest 1981: 44: 214-20.
6. Milich DR. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988: 9: 380-6.
7. Nayersina R, Fowler F, Guilhot S et al. HLA-A2 restricted cytoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B infection. J Immunol 1993: 150: 4659-71.
8. Wooley PH, Griffin J, Fanayi GS et al. HLA-DR antigens and toxic reaction to sodium aurothiomalate and d-penicillamine in patients with rheumatoid arthritis. N Eng J Med 1980: 303: 300-2.
9. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Eng J Med 1989: 321: 708-12.
10. Kruskall MS, Alper CA, Awdeh Z et al. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992: 175: 495-502.
11. Levy M, Chen N. Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80's. Kidney Int 1991: 40 Suppl 35: 24-33.
12. Jung H. Przebieg kliniczny bloniastego klebowego zapalenia nerek u dzieci. Pediatr Pol 1987: 62: 540-6.
13. Wrzolkowa T , Zurowska A, Mrozowicz-Picken M. Hepatitis B virus-associated glomerulonephritis: electron microscopic studies in 98 children. Am J Kidney Dis 1991: 18: 306-12.
14. Kleinknecht C, Levy M, Peix A et al. Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatrics 1979: 95: 946-52.
15. Wiggelinkhuizen J, Sinclair Smith C, Stannard LM et al. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 1983: 58: 488-96.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
17. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
18. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight PCR amplifications with sequence-specific primers (PCR-SSP). Hum Immunol 1993: 37: 201-6.
19. Yoshikawa N, Ito H, Yamada Y et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 1985: 23: 28-34.
20. Jungerman M, Sanchez-Mazas A, Fichna P et al. HLA Class II DRB1, DQA1 and DQB1 polymorphisms in the Polish population from Wielkopolska. Tissue Antigens 1997: 49: 624-8.
21. Krokowski M, Bodalski J, Bratek A et al. HLA class II allele and haplotype distribution in a population from central Poland. Eur J Immunogenet 1998: 25: 5-9.
22. Imanishi T, Akaza T, Kimura A et al. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 1174-8.
23. Sugiura S, Mizokami M, Ortio E et al. DR locus-inclusive HLA in patients with persistent hepatitis B surface antigen In: Zuckerman AJ, ed. Viral hepatitis and liver diseases. New York: Alan R Liss Inc, 1989: 684-7.
24. Watanabe H, Okumura M, Hirayama K et al. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 1990: 36: 69-74.
25. Mineta M, Tanimura M, Tana T et al. Contribution of HLA Class I and II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 1996: 8: 525-31.
26. Walker M, Szmuness W, Stevens C et al. Genetics of Anti-HBs responsiveness. 1. HLA-DR7 and non-responsiveness to hepatitis vaccination [abstract]. Transfusion 1981: 21: 601.
27. Craven DE, Awdeh ZL, Kunches et al. Non-responsiveness to hepatitis B vaccine in health care workers. Ann Intern Med 1986: 105: 356-60.
28. Ajayeb A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994: 344: 1194-95.
29. McDermott AB, Zuckerman JN, Sabin CA et al. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997: 50: 8-14.